Treatment of Lupus Nephritis with anti-CD20 Followed by Anti-BAFF: Impact on B Cell Reconstitution, B Cell Subsets, and Autoreactivity

被引:0
|
作者
Fregoso, Yemil Atisha [1 ]
Malkiel, Susan [1 ]
Harris, Kristina [2 ]
Kanaparthi, Sai [2 ]
Byron, Margie [3 ]
Ding, Linna [4 ]
Smilek, Dawn [5 ]
Wofsy, David [6 ]
Dall'Era, Maria [7 ]
Aranow, Cynthia [1 ]
Diamond, Betty [1 ]
机构
[1] Feinstein Inst Med Res, Manhasset, NY USA
[2] Immune Tolerance Network, Bethesda, MD USA
[3] Rho Fed Syst Inc, Chapel Hill, NC USA
[4] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA
[5] Immune Tolerance Network, San Francisco, CA USA
[6] UCSF, San Francisco, CA USA
[7] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0941
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Phase 2 Trial of Induction Therapy with Anti-CD20 (Rituximab) Followed By Maintenance Therapy with Anti-BAFF (Belimumab) in Patients with Active Lupus Nephritis
    Dall'Era, Maria
    Aranow, Cynthia
    Byron, Margaret
    Ding, Linna
    Smilek, Dawn
    Diamond, Betty
    Wofsy, David
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [2] B cell depletion with Anti-CD20 delays and reverses murine lupus
    Bekar, Kai
    Owen, Teresa
    Dunn, Robert
    Kehry, Marilyn R.
    Anolik, Jennifer H.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S315 - S315
  • [3] Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis
    Roach, Charles A.
    Cross, Anne H.
    FRONTIERS IN NEUROLOGY, 2021, 11
  • [4] Double anti-B cell and anti-BAFF targeting for the treatment of primary Sjogren's syndrome
    Gandolfo, S.
    De Vita, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (03) : S199 - S208
  • [5] Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis
    Roll, Petra
    Palanichamy, Arumugam
    Kneitz, Christian
    Dorner, Thomas
    Tony, Hans-Peter
    ARTHRITIS AND RHEUMATISM, 2006, 54 (08): : 2377 - 2386
  • [6] Dual B Cell Immunotherapy Is Superior to Individual Anti-CD20 Depletion or BAFF Blockade in Murine Models of Spontaneous or Accelerated Lupus
    Lin, WeiYu
    Seshasayee, Dhaya
    Lee, Wyne P.
    Caplazi, Patrick
    McVay, Sami
    Suto, Eric
    Nguyen, Allen
    Lin, Zhonghua
    Sun, Yonglian
    DeForge, Laura
    Balazs, Mercedesz
    Martin, Flavius
    Zarrin, Ali A.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (01) : 215 - 224
  • [7] Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus
    Albert, D.
    Dunham, J.
    Khan, S.
    Stansberry, J.
    Kolasinski, S.
    Tsai, D.
    Pullman-Mooar, S.
    Barnack, F.
    Striebich, C.
    Looney, R. J.
    Prak, E. T. Luning
    Kimberly, R.
    Zhang, Y.
    Eisenberg, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (12) : 1724 - 1731
  • [8] BLOCKING B-CELLS (ANTI-CD20/ANTI-CD20)
    Isenberg, David A.
    RHEUMATOLOGY, 2015, 54 : 1 - 1
  • [9] B cell depletion with anti-CD20 promotes neuroprotection in a BAFF-dependent manner in mice and humans
    Wang, Angela A.
    Luessi, Felix
    Neziraj, Tradite
    Possnecker, Elisabeth
    Zuo, Michelle
    Engel, Sinah
    Hanuscheck, Nicholas
    Florescu, Alexandra
    Bugbee, Eryn
    Ma, Xianjie I.
    Rana, Fatima
    Lee, Dennis
    Ward, Lesley A.
    Kuhle, Jens
    Himbert, Johannes
    Schraad, Muriel
    van Puijenbroek, Erwin
    Klein, Christian
    Urich, Eduard
    Ramaglia, Valeria
    Probstel, Anne-Katrin
    Zipp, Frauke
    Gommerman, Jennifer L.
    SCIENCE TRANSLATIONAL MEDICINE, 2024, 16 (737)
  • [10] Enhanced anti-B-cell tumor effects with anti-CD20 superantibody
    Zhao, YF
    Lou, DY
    Burke, J
    Kohler, H
    JOURNAL OF IMMUNOTHERAPY, 2002, 25 (01): : 57 - 62